A global survey of licensing restrictions for drivers with diabetes

British Journal of Diabetes

View Publication Info
 
 
Field Value
 
Title A global survey of licensing restrictions for drivers with diabetes
 
Creator Beshyah, Salem A; Center for Diabetes and Endocrinology, Sheikh Khalifa Medical City, Abu Dhabi, UAE
Beshyah, Anas S; Institute of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE
Yaghi, Salim; Institute of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE
Beshyah, Waleed S; Institute of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE
Frier, Brian M; The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, UK
 
Subject
driving, diabetes mellitus, licensing regulations, insulin, hypoglycaemia, medical fitness to drive
 
Description Background: Ensuring medical fitness to drive is an important safety measure for people with diabetes and is a prerequisite for a driving licence in many countries. Objectives: To ascertain the current regulatory restrictions on drivers with diabetes currently being applied internationally.Methods: An electronic survey (in English) was sent to contacts of member organisations of the International Diabetes Federation and to selected specialists in diabetes. Questions addressed the regulations in place for insulin-treated drivers. Results: Information on licensing was obtained from 85 countries. No restrictions on drivers with insulin-treated diabetes existed in 59 countries (69.4%). Medical assessment of some type was required in 29 countries (34.5%). They were performed by different people and at different time intervals. Emphasis was placed on conditions causing potential risk to driving safety. When insulin is introduced to a licensed driver’s treatment, in most countries the driver is permitted to continue driving without any change in licensing entitlement (n=68; 80%); in 16 countries (19%) a driver can retain their driving licence subject to special conditions and in one country the driver will have the driving licence revoked permanently. With respect to large goods vehicles and passenger-carrying vehicles, no restrictions or assessments are required for drivers with insulin-treated diabetes in most responding countries (n=56; 66%); licensing is permitted with some restriction in 23 countries (27%) and prohibited in six countries (7%). Conclusions: There is a wide variation between different countries and global regions in the statutory requirements and policies used to regulate and assess drivers with diabetes. The lack of regulation in many countries may adversely affect public safety.
 
Publisher ABCD (Diabetes Care) Ltd
 
Contributor
 
Date 2017-03-21
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

 
Format text/html
application/pdf
 
Identifier http://www.bjd-abcd.com/index.php/bjd/article/view/228
10.15277/bjd.2017.117
 
Source British Journal of Diabetes; Vol 17, No 1 (2017); 3-10
2397-6241
2397-6233
 
Language eng
 
Relation http://www.bjd-abcd.com/index.php/bjd/article/view/228/364
http://www.bjd-abcd.com/index.php/bjd/article/view/228/365
 
Coverage


 
Rights Copyright (c) 2017 British Journal of Diabetes
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2016 Simon Fraser University Library